Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT04573283)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT04573283 Sponsor: Nanfang Hospital, Southern Medical University Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04573283 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult who has been diagnosed with fat in the liver (called hepatic steatosis), confirmed by at least one of the following:
A liver ultrasound scan that shows a "bright liver" (meaning the liver appears brighter than normal on the scan)
A special ultrasound measurement called CAP that gives a reading of 248 or higher (confirm with trial site)
A CT scan, MRI, or a related scan (MRS) that has confirmed fat in the liver
An MRI-based fat measurement (called MRI-PDFF) showing that more than 8% of your liver is made up of fat
A liver biopsy (a small tissue sample taken from the liver) that has confirmed a fatty liver

Who may not be able to join:

People who have been diagnosed with liver cancer or any other type of cancer
People who are currently pregnant
People who have previously had a liver transplant
People who have had a serious heart or brain event, such as a heart attack, stroke, or bleeding in the brain

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8618588531001

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04573283

Sponsor: Nanfang Hospital, Southern Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 8618588531001

More information: https://clinicaltrials.gov/study/NCT04573283

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult who has been diagnosed with fat in the liver (called hepatic steatosis), confirmed by at least one of the following:
A liver ultrasound scan that shows a "bright liver" (meaning the liver appears brighter than normal on the scan)
A special ultrasound measurement called CAP that gives a reading of 248 or higher (confirm with trial site)
A CT scan, MRI, or a related scan (MRS) that has confirmed fat in the liver
An MRI-based fat measurement (called MRI-PDFF) showing that more than 8% of your liver is made up of fat
A liver biopsy (a small tissue sample taken from the liver) that has confirmed a fatty liver

Who may not be able to join:

People who have been diagnosed with liver cancer or any other type of cancer
People who are currently pregnant
People who have previously had a liver transplant
People who have had a serious heart or brain event, such as a heart attack, stroke, or bleeding in the brain

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nanfang Hospital, Southern Medical University

Registry

ClinicalTrials.gov

Start date

17 August 2020

Est. completion

17 August 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

All cause death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov